"The EDSS has a number of limitations and may also measure changes that are not related to MS, such as older age and multiple ...

The use of estrogen replacement therapy (ERT) for the prevention of coronary heart disease (CHD) is discussed. Cardiovascular disease is the number one cause of death in women. It is believed that ...

Introduction Hormone replacement therapy (HRT) can help women experiencing menopausal symptoms, but usage has declined due to uncertainty around risks of cancer and some cardiovascular diseases (CVD).

The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...

The use of short-term hormone therapy for menopause is not associated with long-term cognitive impact after 10 years.

Trial confirms elinzanetant's efficacy and safety in addressing vasomotor symptoms caused by adjuvant endocrine therapy in ...

Menopause is a natural biological process that marks the end of a woman's menstrual cycles, typically occurring in the late ...

Women are continuing to pay between €30 and €70 for their monthly supply of prescribed hormone replacement therapy (HRT), despite being told it would be free of charge from the beginning of this month ...

Breast cancer risks can escalate due to hormonal variances at different life stages. Persistent hormonal imbalances, early menstruation, late menopaus ...

A leading expert on menopause is concerned that the change in attitude towards discussing the natural process is leading some women down the wrong path. The rush to Back in 2020, Dr Ginni Mansberg ...

Women living in rural areas may experience a greater burden of psychological and somatic menopause symptoms, according ...

Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...